Advertisement
Canada markets closed
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7322
    -0.0001 (-0.01%)
     
  • CRUDE OIL

    83.87
    +0.30 (+0.36%)
     
  • Bitcoin CAD

    87,803.84
    -369.78 (-0.42%)
     
  • CMC Crypto 200

    1,386.34
    +3.76 (+0.27%)
     
  • GOLD FUTURES

    2,341.90
    -0.60 (-0.03%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,754.00
    +186.50 (+1.06%)
     
  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    37,584.45
    -44.03 (-0.12%)
     
  • CAD/EUR

    0.6822
    +0.0001 (+0.01%)
     

Estimating The Fair Value Of Amdocs Limited (NASDAQ:DOX)

Does the share price for Amdocs Limited (NASDAQ:DOX) reflect it’s really worth? Today, I will calculate the stock’s intrinsic value by projecting its future cash flows and then discounting them to today’s value. I will be using the Discounted Cash Flows (DCF) model. It may sound complicated, but actually it is quite simple! Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model. Please also note that this article was written in June 2018 so be sure check out the updated calculation by following the link below. View out our latest analysis for Amdocs

The calculation

We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second ‘steady growth’ period. In the first stage we need to estimate the cash flows to the business over the next five years. For this I used the consensus of the analysts covering the stock, as you can see below. I then discount this to its value today and sum up the total to get the present value of these cash flows.

5-year cash flow estimate

2018

2019

2020

2021

2022

Levered FCF ($, Millions)

$387.25

$503.23

$602.50

$740.70

$774.50

Source

Analyst x4

Analyst x4

Analyst x1

Analyst x1

Analyst x1

Present Value Discounted @ 9.37%

$354.07

$420.70

$460.54

$517.68

$494.93

Present Value of 5-year Cash Flow (PVCF)= US$2.25b

ADVERTISEMENT

The second stage is also known as Terminal Value, this is the business’s cash flow after the first stage. The Gordon Growth formula is used to calculate Terminal Value at an annual growth rate equal to the 10-year government bond rate of 2.9%. We discount this to today’s value at a cost of equity of 9.4%.

Terminal Value (TV) = FCF2022 × (1 + g) ÷ (r – g) = US$774.50m × (1 + 2.9%) ÷ (9.4% – 2.9%) = US$12.42b

Present Value of Terminal Value (PVTV) = TV / (1 + r)5 = US$12.42b ÷ ( 1 + 9.4%)5 = US$7.94b

The total value is the sum of cash flows for the next five years and the discounted terminal value, which results in the Total Equity Value, which in this case is US$10.19b. To get the intrinsic value per share, we divide this by the total number of shares outstanding, or the equivalent number if this is a depositary receipt or ADR. This results in an intrinsic value of $71.46. Relative to the current share price of $69.6, the stock is about right, perhaps slightly undervalued at a 2.60% discount to what it is available for right now.

NasdaqGS:DOX Intrinsic Value June 22nd 18
NasdaqGS:DOX Intrinsic Value June 22nd 18

Important assumptions

I’d like to point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. You don’t have to agree with my inputs, I recommend redoing the calculations yourself and playing with them. Because we are looking at Amdocs as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighed average cost of capital, WACC) which accounts for debt. In this calculation I’ve used 9.4%, which is based on a levered beta of 0.911. This is derived from the Bottom-Up Beta method based on comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

Next Steps:

Valuation is only one side of the coin in terms of building your investment thesis, and it shouldn’t be the only metric you look at when researching a company.

For DOX, I’ve compiled three important aspects you should further research:

  1. Financial Health: Does DOX have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.

  2. Future Earnings: How does DOX’s growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.

  3. Other High Quality Alternatives: Are there other high quality stocks you could be holding instead of DOX? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. Simply Wall St does a DCF calculation for every US stock every 6 hours, so if you want to find the intrinsic value of any other stock just search here.


To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.